Standard BioTools
LAB
LAB
112 hedge funds and large institutions have $249M invested in Standard BioTools in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 36 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.08% less ownership
Funds ownership: 91.05% → 87.97% (-3.1%)
10% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 40
Holders
112
Holding in Top 10
1
Calls
$468K
Puts
$127K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$5.01M | |
| 3 | +$3.88M | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$3.39M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.21M |
Top Sellers
| 1 | -$23.4M | |
| 2 | -$14.3M | |
| 3 | -$3M | |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$2.78M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.12M |